Funding for this research was provided by:
Agence Nationale de la Recherche (18-CE17-0008)
Received: 8 September 2022
Accepted: 6 December 2022
First Online: 23 January 2023
: It was nested in a trial aimed at evaluating the safety and efficacy of single doses of levamisole in individuals infected with <i>L. loa</i>. This trial was approved by the Committee on Ethics in Health Sciences Research (no. 226/MRSIT/IRSSA/CERRSSA), and an Administrative Authorization (no. 469/MSP/CAB/UCPP-19) was released by the Ministry of Health and Population of the Congo.
: Not applicable.
: The authors declare that they have no competing interests.